Status:
COMPLETED
The TI.VA Algorithm: A First-in-Humans Test.
Lead Sponsor:
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
Conditions:
Anesthesia
Eligibility:
All Genders
18-65 years
Phase:
NA
Brief Summary
The TI.VA algorithm is a new method to titrate the anesthetic drug concentrations whenever the planned level of anesthesia results to be not appropriate to blunt the patient's reaction to surgical sti...
Detailed Description
The TI.VA algorithm is a new method to titrate the anesthetic drug concentrations whenever the planned level of anesthesia results to be not appropriate to blunt the patient's reaction to surgical sti...
Eligibility Criteria
Inclusion
- The inclusion criteria were: :
- age 18-65 years at the time of recruitment.
- candidates for curative surgery for breast cancer.
- American Society of Anaesthesiologists (ASA) status I/II.
- The exclusion criteria were:
- ASA status \> II.
- counter-indications for use of the drugs employed in this protocol.
- pregnancy or lactation.
- incapacity to understand the study explanation and sign the informed consent form.
- These criteria were selected according to the risk mitigation strategy described in the protocol.
Exclusion
Key Trial Info
Start Date :
December 1 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 31 2021
Estimated Enrollment :
5 Patients enrolled
Trial Details
Trial ID
NCT05199883
Start Date
December 1 2020
End Date
January 31 2021
Last Update
February 3 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Fondazione IRCCS Istituto Nazionale dei Tumori
Milan, Italy, 20133